Portfolio company
Cytomos
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Cytomos develops label-free cell analysis platforms for biopharmaceutical companies to accelerate drug discovery and streamline manufacturing processes.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Spectacell
This company develops a label-free single-cell analysis platform for pharmaceutical and biotechnology organisations to measure the performance of immune therapies.
Zafrens
This company develops a high-throughput single-cell analysis platform for pharmaceutical and biotechnology researchers to conduct simultaneous phenotypic and molecular drug discovery screenings.
LevitasBio
This company develops cellular analysis platforms and sample preparation kits for researchers in the life sciences, pharmaceutical development, and diagnostic sectors.
Charlot Biosciences
This company develops microfluidic hardware for non-destructive live cell analysis and bioprocess monitoring to support biopharmaceutical researchers and cell therapy manufacturers.
ThinkCyte
ThinkCyte develops AI-powered cell analysis and sorting instruments for biopharmaceutical companies and academic institutions to support drug discovery and life science research.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Sampling Human
This company develops single-cell analysis platforms and biocytometry kits for diagnostic, healthcare, and research organisations to improve early disease detection and treatment monitoring.
Constellate Proteomics
This company develops single-molecule protein analysis platforms for biopharmaceutical drug developers to monitor antibody quality and rank cell lines during production.
